FDA backs Pfizer booster for 12- to 15-year-oldsJanuary 3, 2022COVID-19 UpdatesVaccinesPulmonologyInfectious DiseasesHealth Policy
COVID-19 and coping with superimposed traumasDecember 21, 2021PTSDCOVID-19 UpdatesDepressionMental Health
COVID-19 asymptomatic infection rate remains highDecember 15, 2021COVID-19 UpdatesInfectious Diseases
12 state boards have disciplined docs for COVID misinformationDecember 13, 2021Business of MedicineCOVID-19 Updates
Lung transplantation in the era of COVID-19: New issues and paradigmsDecember 13, 2021COVID-19 Updates
Myeloid patients respond robustly to Moderna COVID vaccineDecember 12, 2021COVID-19 UpdatesAMLMyelodysplastic Syndrome
For leukemias, COVID-19 death risks tied to poor prognoses, ICU deferralsDecember 11, 2021COVID-19 UpdatesMyelodysplastic SyndromeAML
Risk for severe COVID-19 and death plummets with Pfizer boosterDecember 9, 2021COVID-19 UpdatesPulmonologyInfectious DiseasesVaccines